Last reviewed · How we verify

NCT03957668

Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation

Status unknown Phase 3 Last updated 20 October 2020
What this trial tests

Phase 3 trial testing PEG 3350 in Constipation - Functional in 184 participants. Status unknown.

Timeline
7 December 2019
Primary endpoint
30 September 2020
31 October 2020

Quick facts

Lead sponsorFakultas Kedokteran Universitas Indonesia
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment184
Start date7 December 2019
Primary completion30 September 2020
Estimated completion31 October 2020
Sites3 locations across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Fakultas Kedokteran Universitas Indonesia — full company profile →

Who can join

18 and older, any sex, with Constipation - Functional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the efficacy and safety of PEG 3350 (polyethylene glycol 3350) for short-term treatment of chronic constipation in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PEG 3350

Trials testing the same drug.

Other recruiting trials for Constipation - Functional

Currently open trials in the same condition.

Other Fakultas Kedokteran Universitas Indonesia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing